Search research articles
Contact Us
Filters
Showing results (1171-1180 of 1,535) with videos related to
Page
of 154
Sort By:
NPJ Precision Oncology
|
September 27, 2025
Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathway
Ivan Juric, Emily E Fink, Hong Qiu, et al.
Molecular Cancer Therapeutics
|
November 18, 2021
Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity
Yiyu Dong, Yongxing Gong, Fengshen Kuo, et al.
Neoplasia (New York, N.Y.)
|
April 10, 2022
Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells
Sara Haddock, Tyler J Alban, Şevin Turcan, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 11, 2014
Population based analysis ependymoma patients in Alberta from 1975 to 2007
Gloria B Roldán Urgoiti, Amitabh D Singh, Roger Y Tsang, et al.
BMC Health Services Research
|
November 30, 2015
Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern Uganda
G Abongomera, S Kiwuwa-Muyingo, P Revill, et al.
Ambio
|
December 15, 2022
An environmental justice perspective on ecosystem services
Jacqueline Loos, Felipe Benra, Marta Berbés-Blázquez, et al.
AIDS Patient Care and Stds
|
July 9, 2021
Loss to Follow-Up and Re-Engagement in HIV Pre-Exposure Prophylaxis Care in the United States, 2013-2019
Jun Tao, Madeline C Montgomery, Robert Williams, et al.
Pancreas
|
November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
Kimberly Perez, Matthew H Kulke, Nora K Horick, et al.
Endocrine-Related Cancer
|
January 12, 2026
Cabozantinib for Advanced Grade 3 Neuroendocrine Tumors: Subgroup Analysis of the Phase 3 CABINET Trial (Alliance A021602)
Jonathan R Strosberg, Tyler Zemla, Susan Geyer, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
August 21, 2023
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study
Josefine Kjaer, Thomas E Clancy, Anders Thornell, et al.
Page
of 154
Search research articles
Search
Showing results (1171-1180 of 1,535) with videos related to
Sort By:
Page
of 154
NPJ Precision Oncology
|
September 27, 2025
Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathway
Ivan Juric, Emily E Fink, Hong Qiu, et al.
Molecular Cancer Therapeutics
|
November 18, 2021
Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity
Yiyu Dong, Yongxing Gong, Fengshen Kuo, et al.
Neoplasia (New York, N.Y.)
|
April 10, 2022
Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells
Sara Haddock, Tyler J Alban, Şevin Turcan, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 11, 2014
Population based analysis ependymoma patients in Alberta from 1975 to 2007
Gloria B Roldán Urgoiti, Amitabh D Singh, Roger Y Tsang, et al.
BMC Health Services Research
|
November 30, 2015
Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern Uganda
G Abongomera, S Kiwuwa-Muyingo, P Revill, et al.
Ambio
|
December 15, 2022
An environmental justice perspective on ecosystem services
Jacqueline Loos, Felipe Benra, Marta Berbés-Blázquez, et al.
AIDS Patient Care and Stds
|
July 9, 2021
Loss to Follow-Up and Re-Engagement in HIV Pre-Exposure Prophylaxis Care in the United States, 2013-2019
Jun Tao, Madeline C Montgomery, Robert Williams, et al.
Pancreas
|
November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
Kimberly Perez, Matthew H Kulke, Nora K Horick, et al.
Endocrine-Related Cancer
|
January 12, 2026
Cabozantinib for Advanced Grade 3 Neuroendocrine Tumors: Subgroup Analysis of the Phase 3 CABINET Trial (Alliance A021602)
Jonathan R Strosberg, Tyler Zemla, Susan Geyer, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
August 21, 2023
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study
Josefine Kjaer, Thomas E Clancy, Anders Thornell, et al.
Page
of 154